trending Market Intelligence /marketintelligence/en/news-insights/trending/qsHBV4sl1op9sdt0MGfS-Q2 content esgSubNav
In This List

Xenetic appoints 3 directors

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Xenetic appoints 3 directors

Adam Logal, James Callaway and Dmitry Genkin joined Xenetic Biosciences Inc.'s board.

Logal is the senior vice president, CFO, chief accounting officer and treasurer of Opko Health Inc. Callaway serves as a corporate strategy consultant at Callaway Innovations.

Genkin is chairman of PJSC Pharmsynthez and previously served on the company's board from 2004 to 2016.